Programmed cell death in human pathogenic fungi - a possible therapeutic target

Area of Science:

• Mycology
• Biochemistry
• Antimicrobial Research

Background:

• Fungal infections are a growing global health threat, causing 1.6 million deaths annually.
• Limited antifungal drug options and rapid fungal adaptation to existing treatments exacerbate the problem.
• Emerging resistance to current antimycotics necessitates novel therapeutic approaches.

Purpose of the Study:

• To review the role of apoptosis in human pathogenic fungi.
• To explore the therapeutic potential of small, antifungal proteins that induce apoptosis.
• To highlight a novel approach for combating fungal infections.

Main Methods:

• Review of existing literature on apoptosis in pathogenic fungi and model organisms.
• Analysis of the properties and mechanisms of small antimicrobial proteins.
• Discussion of the clinical potential of apoptosis-inducing antifungal proteins.

Main Results:

• Small antimicrobial proteins are stable and rarely elicit resistance in fungi.
• Some small proteins induce programmed cell death (apoptosis) in pathogenic fungi.
• These proteins show potential for treating and preventing fungal infections.

Conclusions:

• Small antimicrobial proteins represent a potential new class of antifungal agents.
• Their stability, low resistance development, and synergistic effects suggest future clinical utility.
• Targeting fungal apoptosis offers a novel therapeutic strategy against resistant infections.